Upper tract urothelial cancer

Adam Froemming, Theodora Potretzke, Naoki Takahashi, Bohyun Kim

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

While urothelial carcinoma is a very common tumor, involvement of the upper tract is relatively uncommon. Consequently, there are no consensus imaging recommendations for upper tract disease. CT urography is the dominant imaging modality for the upper tract, but despite its excellent performance characteristics and being widely accepted as standard of care there is great variability in how CTU exams are performed across practices. MR urography has limited current application, but has the potential to become more mainstream in the future with continued technical advances. Upper tract urothelial carcinoma can manifest as a variety of appearances: a papillary lesion, focal wall thickening, focal enhancement, or as an infiltrative lesion. Pelvicalyceal location is about twice as common as in the ureter. Tumors in the pelvicalyceal location often manifest as an irregular enhancing soft tissue attenuation filling defect, and may be sessile or polypoid in morphology. Within the ureter, 73% are located in the distal segment.

Original languageEnglish (US)
Pages (from-to)50-60
Number of pages11
JournalEuropean Journal of Radiology
Volume98
DOIs
StatePublished - Jan 1 2018

Fingerprint

Urography
Ureter
Carcinoma
Standard of Care
Neoplasms

Keywords

  • CTU
  • MRU
  • Urothelial carcinoma imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Froemming, A., Potretzke, T., Takahashi, N., & Kim, B. (2018). Upper tract urothelial cancer. European Journal of Radiology, 98, 50-60. https://doi.org/10.1016/j.ejrad.2017.10.021

Upper tract urothelial cancer. / Froemming, Adam; Potretzke, Theodora; Takahashi, Naoki; Kim, Bohyun.

In: European Journal of Radiology, Vol. 98, 01.01.2018, p. 50-60.

Research output: Contribution to journalReview article

Froemming, A, Potretzke, T, Takahashi, N & Kim, B 2018, 'Upper tract urothelial cancer', European Journal of Radiology, vol. 98, pp. 50-60. https://doi.org/10.1016/j.ejrad.2017.10.021
Froemming A, Potretzke T, Takahashi N, Kim B. Upper tract urothelial cancer. European Journal of Radiology. 2018 Jan 1;98:50-60. https://doi.org/10.1016/j.ejrad.2017.10.021
Froemming, Adam ; Potretzke, Theodora ; Takahashi, Naoki ; Kim, Bohyun. / Upper tract urothelial cancer. In: European Journal of Radiology. 2018 ; Vol. 98. pp. 50-60.
@article{67b889d89e824978b51431c8639a45cc,
title = "Upper tract urothelial cancer",
abstract = "While urothelial carcinoma is a very common tumor, involvement of the upper tract is relatively uncommon. Consequently, there are no consensus imaging recommendations for upper tract disease. CT urography is the dominant imaging modality for the upper tract, but despite its excellent performance characteristics and being widely accepted as standard of care there is great variability in how CTU exams are performed across practices. MR urography has limited current application, but has the potential to become more mainstream in the future with continued technical advances. Upper tract urothelial carcinoma can manifest as a variety of appearances: a papillary lesion, focal wall thickening, focal enhancement, or as an infiltrative lesion. Pelvicalyceal location is about twice as common as in the ureter. Tumors in the pelvicalyceal location often manifest as an irregular enhancing soft tissue attenuation filling defect, and may be sessile or polypoid in morphology. Within the ureter, 73{\%} are located in the distal segment.",
keywords = "CTU, MRU, Urothelial carcinoma imaging",
author = "Adam Froemming and Theodora Potretzke and Naoki Takahashi and Bohyun Kim",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ejrad.2017.10.021",
language = "English (US)",
volume = "98",
pages = "50--60",
journal = "European Journal of Radiology",
issn = "0720-048X",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Upper tract urothelial cancer

AU - Froemming, Adam

AU - Potretzke, Theodora

AU - Takahashi, Naoki

AU - Kim, Bohyun

PY - 2018/1/1

Y1 - 2018/1/1

N2 - While urothelial carcinoma is a very common tumor, involvement of the upper tract is relatively uncommon. Consequently, there are no consensus imaging recommendations for upper tract disease. CT urography is the dominant imaging modality for the upper tract, but despite its excellent performance characteristics and being widely accepted as standard of care there is great variability in how CTU exams are performed across practices. MR urography has limited current application, but has the potential to become more mainstream in the future with continued technical advances. Upper tract urothelial carcinoma can manifest as a variety of appearances: a papillary lesion, focal wall thickening, focal enhancement, or as an infiltrative lesion. Pelvicalyceal location is about twice as common as in the ureter. Tumors in the pelvicalyceal location often manifest as an irregular enhancing soft tissue attenuation filling defect, and may be sessile or polypoid in morphology. Within the ureter, 73% are located in the distal segment.

AB - While urothelial carcinoma is a very common tumor, involvement of the upper tract is relatively uncommon. Consequently, there are no consensus imaging recommendations for upper tract disease. CT urography is the dominant imaging modality for the upper tract, but despite its excellent performance characteristics and being widely accepted as standard of care there is great variability in how CTU exams are performed across practices. MR urography has limited current application, but has the potential to become more mainstream in the future with continued technical advances. Upper tract urothelial carcinoma can manifest as a variety of appearances: a papillary lesion, focal wall thickening, focal enhancement, or as an infiltrative lesion. Pelvicalyceal location is about twice as common as in the ureter. Tumors in the pelvicalyceal location often manifest as an irregular enhancing soft tissue attenuation filling defect, and may be sessile or polypoid in morphology. Within the ureter, 73% are located in the distal segment.

KW - CTU

KW - MRU

KW - Urothelial carcinoma imaging

UR - http://www.scopus.com/inward/record.url?scp=85032915996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032915996&partnerID=8YFLogxK

U2 - 10.1016/j.ejrad.2017.10.021

DO - 10.1016/j.ejrad.2017.10.021

M3 - Review article

C2 - 29279170

AN - SCOPUS:85032915996

VL - 98

SP - 50

EP - 60

JO - European Journal of Radiology

JF - European Journal of Radiology

SN - 0720-048X

ER -